Business
Johnson & Johnson: Biotech a shot in the arm for future growth? on January 9, 2024 at 12:43 am Entrepreneur: Latest Articles
Johnson & Johnson is actively shifting its strategy towards biotechnology and antibody-drug conjugates, balancing current revenue protection with future growth.
Finance Johnson & Johnson is actively shifting its strategy towards biotechnology and antibody-drug conjugates, balancing current revenue protection with future growth.